EG00229 T11153
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
EG00229 selectively inhibits VEGF-A binding to NRP1 b1 domain with an IC50 of 3 _M, but has no effect on VEGFA binding to VEGFR-1 and VEGFR-2. EG00229 is a neuropilin 1 (NRP1) receptor antagonist.
CAS nr:
1210945-69-9
Purity:
98%
Molecular Weight:
611,6
SMILES:
N=C(N)NCCC[C@@H](C(O)=O)NC(C1=C(NS(=O)(C2=CC=CC3=NSN=C32)=O)C=CS1)=O.O=C(O)C(F)(F)F
Formula:
C19H20F3N7O7S3
Pathway:
Others
Target:
Others
